CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease

Andrew F. Tyler, Jason P. Mendoza, Mihail Firan, Nitin J. Karandikar

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds